Skip to main content
SpringerLink
Log in

Colitis ulcerosa

  • Chapter
Darmkrankheiten

Zusammenfassung

Bei der Colitis ulcerosa (Synonym: „ulcerative colitis“ „recto-colite hémorragique“, „Colitis gravis“) handelt es sich um eine chronische Entzündung der kolorektalen Schleimhaut, die durch akute Exazerbationen mit oft blutigen Diarrhöen und Remissionen charakterisiert ist. Der Befall ist im Unterschied zum M. Crohn in aller Regel kontinuierlich, vom Rektum ausgehend und kann unterschiedlich weitreichend das gesamte Kolon, gelegentlich auch das terminale Ileum („Backwash-Ileitis“), erfassen. Sie führt in der Regel zu ausgedehnten Schleimhautulzerationen und in wechselnder Häufigkeit auch zu extraintestinalen Krankheitsmanifestationen.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 64.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 84.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  • Allgayer H, Kruis W (1996) Salazosulfapyridin und 5-Aminosalicylsäure. In: Fischbach W (Hrsg) Therapiekonzepte Morbus Crohn-Colitis ulcerosa, S 9–15

    Google Scholar 

  • Ardizzone S, Molteni F, Imbesi V, Bollani S, Bianchi Porro G (1997) Azathioprine in steroid-resistant and steroid-dependent ulcerative colitis. J Clin Gastroenterol 25:330–333

    Article  PubMed  CAS  Google Scholar 

  • Ardizzone S, Moltini P, Bollani S, Porro GB (1997) Guidelines for the treatment of ulcerative colitis in remission. Eur J Gastroenterol Hepatol 9:836–841

    PubMed  CAS  Google Scholar 

  • Ardizzone S, Porro GB (1996) The topical treatment of distal ulcerative colitis. Eur J Gastroenterol Hepatol 8:599–602

    Article  PubMed  CAS  Google Scholar 

  • Atkinson KA, McDonald JW, Lamba B, Feagan BG (1997) Intravenous cyclosporine for severe attacks of ulcerative colitis: a survey of Canadian gastroenterologists. Can J Gastroenterol 11:583–587

    PubMed  CAS  Google Scholar 

  • Becker JM (1998) Ulcerative colitis and colon carcinoma: epidemiology, surveillance, diagnosis, and treatment. The SSAT, AGA, ASLD, ASGE, AHPBA Consensus panel. J Gastrointest Surg 2:305–306

    Article  Google Scholar 

  • Bernstein CN, Shanahan F, Weinstein WM (1994) Are we telling the truth about surveillance colonoscopy in ulcerative colitis. Lancet 343:71–74

    Article  PubMed  CAS  Google Scholar 

  • Collins CE, Benson MJ, Burnham WR, Rampton DS (1996) Picotamide inhibition of excess in vitro thromboxane B2 release by colorectal mucosa in inflammatory bowel disease. Aliment Pharmacol Ther 10:315–320

    Article  PubMed  CAS  Google Scholar 

  • Cohen Z, Smith D, McLeod R (1998) Reconstructive surgery for pelvic pouches. World J Surg 22:342–346

    Article  PubMed  CAS  Google Scholar 

  • Compton RF, Sandborn WJ, Lawson GM et al. (1997) A doseranging pharmacokinetic study of nicotine tartrate following single-dose delayed-release oral and intravenous administration. Aliment Pharmacol Ther 11:865–874

    Article  PubMed  CAS  Google Scholar 

  • Cummings JH (1997) Short-chain fatty acid enemas in the treatment of distal ulcerative colitis. Eur J Gastroenterol Hepatol 9:149–153

    PubMed  CAS  Google Scholar 

  • Dignass A, Goebell H (1996) Fortschritte in der Ätiologie-und Pathogeneseforschung der chronisch entzündlichen Darmerkrankungen. Der Internist 39:1004–1012

    Article  Google Scholar 

  • Egan LJ, Sandborn WJ (1996) Methotrexate for inflammatory bowel disease: pharmacology and preliminary results. Mayo Clin Proc 71:69–80

    Article  PubMed  CAS  Google Scholar 

  • Evans RC, Wong VS, Morris AI, Rhodes JM (1997) Treatment of corticoid-resistant ulcerative colitis with heparin — a report of 16 cases. Aliment Pharmacol Ther 11:1037–1040

    Article  PubMed  CAS  Google Scholar 

  • Feagan BG (1996) Oral budesonide therapy for ulcerative colitis: a topical tale. Gastroenterology 110: 2000–2002

    Article  PubMed  CAS  Google Scholar 

  • Fiocchi C, Fukushima K, Strong SA, Ina K (1996) Pitfalls in cytokine analysis in inflammatory bowel disease. Aliment Pharmacol Ther 10 Suppl 2:63–69; discussion 70–71

    PubMed  CAS  Google Scholar 

  • Gionchetti P, Venturi A, Rizzello F et al. (1997) Retrograde colonic spread of a new mesalazine rectal enema in patients with distal ulcerative colitis. Aliment Pharmacol Ther 11: 679–684

    Article  PubMed  CAS  Google Scholar 

  • Green JT, Thomas GA, Rhodes J, et al. (1997) Nicotine enemas for active ulcerative colitis — a pilot study. Aliment Pharmacol Ther 11:859–863

    Article  PubMed  CAS  Google Scholar 

  • Griffin MG, Miner PB (1996) Refractory distal colitis — explanations and options. Aliment Pharmacol Ther 10:39–48

    Article  PubMed  CAS  Google Scholar 

  • Hamedani R, Feldman RD, Feagan BG (1997) Drug development in inflammatory bowel disease: budesonide — a model of targeted therapy. Aliment Pharmacol Ther 11 Suppl 3:98–107

    PubMed  CAS  Google Scholar 

  • Hanauer SB (1996) Drug Therapy: Inflammatory Bowel Disease. N Engl J Med 334:841–848

    Article  PubMed  CAS  Google Scholar 

  • von Herbay A (1998) Karzinome bei chronisch entzündlichen Darmerkrankungen. Der Internist 10:1024–1029

    Article  Google Scholar 

  • Heppell J, Kelly KA (1998) Pouchitis. Curr Opin Gastroenterol 14:322–326

    Article  Google Scholar 

  • Herfarth C, Stern J (1990) Colitis ulcerosa — Adenomatosis coli. Springer Verlag, Berlin Heidelberg New York Tokyo

    Book  Google Scholar 

  • Hulten L (1998) Proctocolectomy and ileostomy to pouch surgery for ulcerative colitis. World J Surg 22:335–341

    Article  PubMed  CAS  Google Scholar 

  • Hyde GM, Jewell DP (1997) The management of severe ulcerative colitis. Aliment Pharmacol Ther 11:419–424

    Article  PubMed  CAS  Google Scholar 

  • Jewell DP (1998) Ulcerative Colitis. In: Feldman M, Scharschmidt BF, Sleisenger MH (Hrsg) Sleisenger & Fordtran’s Gastrointestinal and Liver Disease, 6nd ed. WB Saunders Company, Philadelphia, S 1735–1761

    Google Scholar 

  • Kenyon CJ, Nardi RV, Wong D, Hooper G, Wilding IR, Friend DR (1997) Colonic delivery of dexamethasone: a pharmaco scintigraphic evaluation. Aliment Pharmacol Ther 11:205–213

    Article  PubMed  CAS  Google Scholar 

  • Köhler LW, Pemberton JH, Zinsmeister AR, Kelly KA, Dozois R (1991) Quality of life after proctocolectomy. Gastroenterology 101:679–684

    PubMed  Google Scholar 

  • Kornbluth A, Present DH, Lichtiger S, Hanauer S (1997) Cyclosporin for severe ulcerative colitis: a user’s guide. Am J Gastroenterol 92:1424–1428

    PubMed  CAS  Google Scholar 

  • Kornbluth A, Sachar DB (1997) Ulcerative colitis practice guidelines in adults. American College of Gastroenterology, Practice Parameters Committee. Am J Gastroenterol 92:204–211

    PubMed  CAS  Google Scholar 

  • Kruis W, Schutz E, Fric P, Fixa B, Judmaier G, Stolte M (1997) Double-blind comparison of an oral Escherichia coli preparation and mesalazine in maintaining remission of ulcerative colitis. Aliment Pharmacol Ther 11:853–858

    Article  PubMed  CAS  Google Scholar 

  • Lamers CBHW (1997) Teatment of extraintestinal complications of ulcerative colitis. Eur J Gastroenterol Hepatol 9: 850–853

    PubMed  CAS  Google Scholar 

  • Marion JF, Present DH (1997) The modern medical management of acute, severe ulcerative colitis. Eur J Gastroenterol Hepatol 9:831–835

    PubMed  CAS  Google Scholar 

  • McLeod RS, Cohen Z (1998) Restorative proctocolectomy with stapled ileal pouch-anal anastomosis. In: Rachmilewitz D: V International Symposium on Inflammatory Bowel Diseases. Kluwer Dordrecht, Netherlands: 188–195

    Google Scholar 

  • McLeod RS, Churchill DN, Lock AM (1991) Quality of life of patients with ulcerative colitis preoperatively and postoperatively. Gastroenterology 101:1307–1313

    PubMed  CAS  Google Scholar 

  • Modigliani R (1997) Drug therapy for ulcerative colitis during pregnancy. Eur J Gastroenterol Hepatol 9:854–857

    PubMed  CAS  Google Scholar 

  • Moody GA, Jayanthi V, Probert CS, Mac Kay H, Mayberry JF (1996) Long-term therapy with sulphasalazine protects against colorectal cancer in ulcerative colitis: a retrospective study of colorectal cancer risk and compliance with treatment in Leicestershire. Eur J Gastroenterol Hepatol 8:1179–1183

    Article  PubMed  CAS  Google Scholar 

  • Nicholls RJ, Banerjee AK (1998) Pouchitis: risk factors, etiology, and treatment. World J Surg 22:347–351

    Article  PubMed  CAS  Google Scholar 

  • Otto HF, Remmele W (1996) Kolon und Rektum. In: Remmele W (Hrsg) Pathologie, Band 2 (Verdauungstrakt). Springer-Verlag Berlin Heidelberg, S 533–676

    Google Scholar 

  • Pemberton JH (1998) Mayo experience with two-stage proctocolectomy and ileal pouch-anal anastomosis. In: Rachmilewitz D, V International Symposium on Inflammatory Bowel Diseases. Kluwer Dordrecht, Netherlands 196–203

    Google Scholar 

  • Peterson TC, Davey K (1997) Effect of acute pentoxifylline treatment in an experimental model of colitis. Aliment Pharmacol Ther 11:575–580

    Article  PubMed  CAS  Google Scholar 

  • Pinczowski D, Ekbom A, Baron J, Yuen J, Adami HO (1994) Risk factors for colorectal cancer in patients with ulcerative colitis: a case-control study. Gastroenterology 107: 117–120

    PubMed  CAS  Google Scholar 

  • Rask-Madson J (1997) From the basic to future medical options for the treatment of ulcerative colitis. Eur J Gastroenterol Hepatol 9:864–871

    Google Scholar 

  • Roberts WG, Simon TJ, Berlin RG et al. (1997) Leukotrienes in ulcerative colitis: results of a multicenter trial of a leukotriene biosynthesis inhibitor, MK-591. Gastroenterology 112:725–732

    Article  PubMed  CAS  Google Scholar 

  • Sachar DB (1997) Inflammatory Bowel Disease: Recent Advances in Pharmacotherapy. Gastro Dis Today 6:9–15

    Google Scholar 

  • Sandborn WJ, Hanauer SB (1999) Antitumor necrosis factor therapy for inflammatory bowel disease: A review of agents, pharmacology, clinical results and safety. Inflammatory Bowel Diseases 5:119–133

    Article  PubMed  CAS  Google Scholar 

  • Schölmerich J (1997) Immunsuppressive treatment for refractory ulcerative colitis-where do we stand and where are we going. Eur J Gastroenterol Hepatol 9:842–849

    PubMed  Google Scholar 

  • Schreiber S, Hastensen TS, Brandtzaeg P, MacDermott RP (1994) Role of B-cell-dependent effector mechanisms in inflammatory bowel disease. In: Targan SR, Shanahan F (Hrsg) Inflammatory bowel disease. From bench to bedside. Williams & Wilkins Baltimore, S 89–105

    Google Scholar 

  • Seow-Choen Tsunoda A, Nicholls RJ (1991) Prospective randomized trial comparing anal function after hand sewn ileoanal anastomosis with mucosectomy versus stapled ileoanal anastomosis without mucosestomy in restorative proctocolectomy. Br J Surg 79:430–443

    Article  Google Scholar 

  • Sheth SG, La Mont JT (1998) Toxic megacolon. Lancet 351:509–513

    Article  PubMed  CAS  Google Scholar 

  • Stack WA, Long RG, Hawkey CJ (1998) Short-and longterm outcome of patients treated with cyclosporin for severe acute colitis. Aliment Pharmacol Ther 12:973–978

    Article  PubMed  CAS  Google Scholar 

  • Stein E (1997) Entzündliche Erkrankungen des Dickdarms, Anorekzums und Perianalbereichs. In: Stein E (Hrsg) Proktologie (3. Auflage) Springer-Verlag Berlin Heidelberg, S 337–366

    Google Scholar 

  • Steinhart AH, Hiruki T, Brzezinski A, Baker JP (1996) Treatment of left-sided ulcerative colitis with butyrate enemas: a controlled trial. Aliment Pharmacol Ther 10:729–736

    Article  PubMed  CAS  Google Scholar 

  • Van Bodegraven AA, Tuynman HA, Schoorl M, Kruishoop AM, Bartels PC (1995) Fibrinolytic split products, fibrinolysis, and factor XIII activity in inflammatory bowel disease. Scand J Gastroenterol 30:580–585

    Article  PubMed  Google Scholar 

  • van Deventer SJ, Camoglio L (1996) Monoclonal antibody therapy of inflammatory bowel disease. Aliment Pharmacol Ther 10 Suppl 2:107–111; discussion 112

    PubMed  Google Scholar 

  • Wikberg M, Ulmius J, Ragnarsson G (1997) Review article: Targeted drug delivery in treatment of intestinal diseases. Aliment Pharmacol Ther 11 Suppl 3:109–115

    PubMed  Google Scholar 

Download references

Authors
  1. J. Stein
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. F. Makowiec
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. R. M. Starlinger
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. W. F. Caspary
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Medizinische Klinik II Zentrum der Inneren Medizin, Johann Wolfgang Goethe Universität, Theodor-Stern-Kai 7, 60950, Frankfurt/Main, Deutschland

    Wolfgang F. Caspary  & Jürgen Stein  & 

Rights and permissions

Reprints and permissions

Copyright information

© 1999 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Stein, J., Makowiec, F., Starlinger, R.M., Caspary, W.F. (1999). Colitis ulcerosa. In: Caspary, W.F., Stein, J. (eds) Darmkrankheiten. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-59960-6_43

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-59960-6_43

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-64197-8

  • Online ISBN: 978-3-642-59960-6

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation